Insights from the NeoIPC webinar on outbreak management in neonatal intensive care units
10 Mar, 2023
On 9 March 2023, the NeoIPC Clinical Practice Network held a webinar titled “Protecting our tiniest patients: Strategies for managing NICU outbreaks”. The event was a great success, with 78…
Read More
PentaTr@ining: ‘AMR Online Course’ kicks-off!
20 Feb, 2023
On February 20th 2023, we kicked off our exciting brand-new PentaTr@ining programme ‘AMR Online Course’. This innovative training will offer a bespoke interactive learning platform for a global audience, ensuring the sharing…
Read More
Register for the webinar “Protecting our tiniest patients: Strategies for managing NICU outbreaks”
17 Feb, 2023
Neonatal intensive care units (NICUs) are essential facilities for preterm and sick newborns. Unfortunately, NICUs are also exposed to infectious disease outbreaks that may put these tiny patients at risk. …
Read More
An optimised dosing regimen vs. a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in infants less than 90 days: the NeoVanc trial
14 Feb, 2023
Background: Vancomycin remains one of the most widely prescribed antibiotics for Gram-positive neonatal late onset sep- sis (LOS). Robust neonatal clinical outcome data comparing different vancomycin dosing regimens is lacking.…
Read More
Interim pharmacokinetic analysis of a multi-centre randomised open label phase IIb study in neonates to validate the meta-analysis population pharmacokinetic model used to simulate an optimised dosing regimen in neonates and infants aged < 90 days: the NeoVanc trial
14 Feb, 2023
Background: Vancomycin remains one of the most widely prescribed antibiotics for Gram-positive neonatal late onset sepsis (LOS), however, a consensus on optimal vancomycin dosing and duration is lacking. Robust neonatal…
Read More
MRC Clinical Trials Unit Capacity Strengthening Hub launches!
08 Feb, 2023
We are excited to share that our partner, MRC CTU at UCL, launched the MRC Clinical Trials Unit (MRC CTU) has launched a Capacity Strengthening Hub on 31st January! The aim of…
Read More
Registrations are open for ‘PentaTr@ining: AMR Online Course’!
03 Feb, 2023
We are happy to announce that registrations are now open* for our new interactive training programme – ‘PentaTr@ining: AMR Online Course’! This timely course brings together doctors, nurses, pharmacists and…
Read More
TEAM-COACH: a new project to train and build capacity in antimicrobial stewardship and infection prevention and control in children
30 Jan, 2023
A new project, Training and capacity building in antimicrobial stewardship and infection prevention and control in children through an interactive electronic tool and a European collaborative group – in short TEAM-COACH (GA 101079939)- has…
Read More
HIPRA’s COVID-19 vaccine trial in people with immunocompromising conditions launches in Turkey
19 Jan, 2023
One of the objectives of the RBDCOV project is to test whether their vaccine can reactivate or re-generate a protective immune response to SARS-CoV-2 in immunocompetent and immunosuppressed individuals Accordingly,…
Read More
Two-thirds recruitment milestone reached for PediCAP!
11 Jan, 2023
We are pleased to have reached the two-thirds recruitment milestone with more than 750 children admitted to hospital with severe or very severe pneumonia, now recruited into the PediCAP trial.…
Read More
Get to know the UNIVERSAL project: Pharmacokinetic study of new DTG/FTC/TAF dose ratio
09 Jan, 2023
Welcome to the of the “Get to know the UNIVERSAL project” series! Here we will introduce you to the various work packages and facets that make up the UNIVERSAL project.…
Read More
2022 End of Year Message from the President of the Penta Foundation, Carlo Giaquinto
30 Dec, 2022
It’s been an incredible year, and Penta is well and thriving. We have worked hard and accomplished so much, none of which would have been possible without our partners, collaborators…
Read More
Get to know the UNIVERSAL project: Assessing the long-term safety of ART drugs
20 Dec, 2022
Welcome to the “Get to know the UNIVERSAL project” series! Here we will introduce you to the various work packages and facets that make up the UNIVERSAL project. Assessing the…
Read More
PentaTr@ining: ‘Fungal Infections in Paediatrics’ online course wraps up!
20 Dec, 2022
The first ever edition of our brand-new online training course ‘Fungal Infections in Paediatrics’ came to a close on 15th December 2022. We are delighted to report we had an…
Read More
WHO publishes the AWaRe (Access, Watch, Reserve) Antibiotic Book
12 Dec, 2022
The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book has been recently published on the WHO website. It is the first global guidance on antibiotic use to treat more than 30…
Read More
Experts call for urgent action to develop antibiotics for newborns
07 Dec, 2022
Leading public health experts from around the globe are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly vulnerable to antibiotic resistance. The urgent…
Read More
‘PentaTr@ining: Viral Hepatitis in Children’ – online course launches!
05 Dec, 2022
On 5th December 2022, over 200 delegates from around the globe logged in for the kick-off of our exciting new online training course “PentaTr@ining: Viral Hepatitis in Children”. This interactive course, run on the dedicated PentaTr@ining virtual learning platform, will provide a space for students and faculty to work together and collaboratively solve problems…
Read More
World AIDS Day 2022: Is HIV cure attainable in our lifetime?
30 Nov, 2022
In the lead-up to #WorldAIDSDay2022, people wonder, is an HIV cure attainable in our lifetime? Yes, we believe there are good reasons to be optimistic about a cure!
Read More